News
Kennedy Jr.'s layoffs. Kennedy initially planned to cut 3,500 employees from the FDA. In team-wide meetings that started last week, multiple FDA employees said they were informed by their ...
Evolving regulatory paradigms governing AI use in health care at the U.S. Food and Drug Administration (FDA) have set the pace for AI ...
A federal judge Thursday extended a temporary restraining order blocking President Donald Trump's administration from ...
Biohaven is giving investors whiplash. Forty-eight hours after saying its filing was on track, the biopharma revealed the FDA ...
Companies that interact with FDA are likely to find that the layoff of 3,500 employees on April 1, 2025, affects their dealings in a variety of ways. The cuts will likely have the greatest impact ...
Layoffs at HHS create opportunities for local biotech and life sciences companies to add talent and prevent what many fear ...
The U.S. Food and Drug Administration plans to step up safety reviews on chemicals in foods, including one widely used as a ...
The FDA also changed its tune and is now planning to convene an advisory committee to discuss Biohaven’s application.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results